RxDoctor Payments Data

William Rush, MD

Urogynecology and Reconstructive Pelvic Surgery · Dayton, OHNPI 1295858355

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,814 of the $2,503 with a category attached, or 72.5%. Medtronic accounts for 85.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $1,145, 6.0 times the $192 reported in 2019. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in OH, where the typical reported total is $3,689.

$2,503in general payments, 2019–2025

Across 39 payments — averaging $64.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Axonics, Inc.$168
  • Baxter Healthcare$51
  • Therapeuticsmd, Inc.$31
  • AbbVie$26
  • Exact Sciences$23
  • plus $69 from 4 others
$473in research payments, 2019–2025

Across 2 payments — averaging $236.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$473

What the payments were for

  • Travel & lodging$68928%
  • Food & beverage$1,81472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,503 in reported general payments places this provider in the 35th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.

See all urogynecology and reconstructive pelvic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$148,732
Medicare patients
177
Services billed
678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trospium Chloride ErTrospium Chloride11$1,255
Trospium Chloride15$1,214
Estradiol20$1,105
Methenamine Hippurate15$650
Trimethoprim17$411
CefuroximeCefuroxime Axetil23$248
Fluconazole14$215
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst24$184
Tamsulosin Hcl33$118
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$111
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim31$63
Naproxen14$51

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →